# Gastric Cancer Metastasis to the Prostate Detected on 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (18F-FDG PET/CT): A Report of a Rare Case

**Authors:** Ryo Sato, Asuka Uchiyama, Daisuke Suzuki, Yukihiro Yoshimi, Tetsuharu Nishio, Yu Matsunaga, Rikiya Matsumoto

PMC · DOI: 10.7759/cureus.88048 · Cureus · 2025-07-16

## TL;DR

A rare case of gastric cancer metastasizing to the prostate was detected using 18F-FDG PET/CT when other imaging methods failed.

## Contribution

Highlights the rare metastatic pattern of gastric cancer to the prostate and the utility of PET/CT in such cases.

## Key findings

- 18F-FDG PET/CT identified a prostate lesion not seen on CT or endoscopy.
- Histology confirmed metastatic gastric cancer in the prostate.
- PSA was mildly elevated but not specific for prostate cancer.

## Abstract

We report an exceptionally rare case of prostate metastasis in a 70-year-old man with a history of gastric cancer. Following distal gastrectomy (pT4aN0M0) and one year of adjuvant chemotherapy with S-1, he remained recurrence-free until a gradual rise in serum carbohydrate antigen 19-9 was observed, reaching 1878.97 U/mL. Contrast-enhanced computed tomography and esophagogastroduodenoscopy failed to identify a site of recurrence. However, 18F-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT) detected abnormal uptake at the apex of the prostate, with a maximum standardized uptake value of 11. Magnetic resonance imaging was non-contributory, and serum prostate-specific antigen (PSA) was mildly elevated at 6.04 ng/mL. A transrectal ultrasound-guided prostate biopsy revealed poorly differentiated adenocarcinoma. Immunohistochemistry was negative for PSA and NKX3.1, but positive for cytokeratin 7, and histological comparison with the prior gastric specimen confirmed metastatic gastric cancer to the prostate. This case underscores the diagnostic challenge posed by rare metastatic patterns and highlights the complementary value of 18F-FDG PET/CT in detecting occult lesions when conventional imaging fails. In patients with a history of gastric cancer and rising tumor markers, early consideration of PET/CT followed by histological confirmation may facilitate timely and accurate diagnosis.

## Linked entities

- **Proteins:** KLK3 (kallikrein related peptidase 3), NKX3-1 (NK3 homeobox 1)
- **Chemicals:** 18F-fluorodeoxyglucose (PubChem CID 68614), carbohydrate antigen 19-9 (PubChem CID 643993), S-1 (PubChem CID 1497102)
- **Diseases:** gastric cancer (MONDO:0001056), prostate cancer (MONDO:0005159)

## Full-text entities

- **Genes:** KRT7 (keratin 7) [NCBI Gene 3855] {aka CK7, K2C7, K7, SCL}, KLK3 (kallikrein related peptidase 3) [NCBI Gene 354] {aka APS, KLK2A1, PSA, hK3}, NKX3-1 (NK3 homeobox 1) [NCBI Gene 4824] {aka BAPX2, NKX3, NKX3.1, NKX3A}
- **Diseases:** gastric (MESH:D013272), tumor (MESH:D009369), Metastasis to (MESH:D009362), Prostate (MESH:D011472), Gastric Cancer (MESH:D013274), adenocarcinoma (MESH:D000230)
- **Chemicals:** 18F-FDG (MESH:D019788), S-1 (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12357750/full.md

## Figures

3 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12357750/full.md

## References

9 references — full list in the complete paper: https://tomesphere.com/paper/PMC12357750/full.md

---
Source: https://tomesphere.com/paper/PMC12357750